Paul David Brown
#138,753
Most Influential Person Now
Paul David Brown's AcademicInfluence.com Rankings
Paul David Brownphilosophy Degrees
Philosophy
#7136
World Rank
#10303
Historical Rank
Logic
#4210
World Rank
#5472
Historical Rank
Paul David Brownbiology Degrees
Biology
#9690
World Rank
#12923
Historical Rank
Neuroscience
#1427
World Rank
#1477
Historical Rank
Download Badge
Philosophy Biology
Paul David Brown's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine Stanford University
Similar Degrees You Can Earn
Why Is Paul David Brown Influential?
(Suggest an Edit or Addition)Paul David Brown's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014) (2145)
- Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. (2012) (1153)
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. (2016) (1059)
- Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. (2009) (877)
- Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. (2013) (771)
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. (2016) (722)
- A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. (2006) (693)
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. (2017) (690)
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. (2013) (681)
- Response assessment criteria for brain metastases: proposal from the RANO group. (2015) (553)
- Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) (2017) (466)
- Whole-brain radiotherapy in the management of brain metastasis. (2006) (425)
- Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. (2017) (391)
- Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. (2013) (366)
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data (2018) (336)
- Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. (2006) (328)
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (2020) (326)
- A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. (2003) (321)
- Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. (2012) (317)
- Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. (2006) (316)
- Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. (2012) (296)
- Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. (2013) (278)
- The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. (2007) (277)
- Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. (2008) (274)
- Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. (2012) (266)
- Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. (2008) (257)
- Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response (2006) (242)
- Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. (2003) (232)
- Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. (2003) (212)
- Central nervous system tumors. (2007) (203)
- Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. (2007) (203)
- A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival (2005) (193)
- Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. (2007) (173)
- Radiosurgery for arteriovenous malformations of the basal ganglia, thalamus, and brainstem. (2004) (170)
- Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas (2006) (170)
- Cognitive sequelae of brain radiation in adults. (2004) (169)
- Phase 1/2 trial of single‐session stereotactic body radiotherapy for previously unirradiated spinal metastases (2012) (167)
- Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. (2008) (167)
- Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. (2009) (156)
- Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data. (2019) (149)
- Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. (2013) (148)
- Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). (2017) (148)
- Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. (2016) (147)
- Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. (2005) (145)
- Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials. (2019) (133)
- STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH “RADIORESISTANT” BRAIN METASTASES (2002) (129)
- Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. (2011) (128)
- Radiosurgery for Cranial Base Chordomas and Chondrosarcomas (2005) (127)
- Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. (2020) (127)
- Central neurocytoma: management recommendations based on a 35-year experience. (2007) (126)
- Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. (2018) (126)
- The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer (2013) (124)
- RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). (2013) (124)
- Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? (2017) (123)
- Properly Selected Patients with Multiple Brain Metastases May Benefit from Aggressive Treatment of their Intracranial Disease (2004) (123)
- RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). (2011) (119)
- Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. (2013) (115)
- Outcome in adult low-grade glioma (2007) (114)
- Prognosis and treatment of spinal cord astrocytoma. (2009) (113)
- A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K. (2015) (113)
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. (2013) (109)
- A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. (2005) (108)
- Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG (2015) (104)
- Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. (2008) (102)
- The radiosurgery fractionation quandary: single fraction or hypofractionation? (2017) (100)
- Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. (2021) (97)
- New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. (2013) (96)
- Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (2012) (96)
- Prospective Randomized Trial of Post-operative Stereotactic Radiosurgery versus Observation for Completely Resected Brain Metastases (2017) (95)
- Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. (2006) (95)
- Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). (2020) (94)
- A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images (2018) (93)
- Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. (2013) (92)
- Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. (2014) (91)
- Long-term results of irradiation for paraganglioma. (2006) (91)
- Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. (2020) (90)
- Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence. (2015) (90)
- Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. (2006) (89)
- Stereotactic radiosurgery for patients with "radioresistant" brain metastases. (2002) (88)
- Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer (2013) (86)
- Single-fraction radiosurgery of benign intracranial meningiomas. (2012) (85)
- Will Improvement in Quality of Life (QOL) Impact Fatigue in Patients Receiving Radiation Therapy for Advanced Cancer? (2006) (79)
- Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. (2017) (79)
- Postoperative Proton Therapy for Chordomas and Chondrosarcomas of the Spine: Adjuvant Versus Salvage Radiation Therapy (2015) (77)
- The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. (2016) (77)
- Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. (2004) (76)
- Stereotactic body radiation therapy in spinal metastases. (2012) (75)
- Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. (2008) (74)
- Radiosurgery to the postoperative surgical cavity: who needs evidence? (2012) (73)
- Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001 (2018) (72)
- Utilization of laser interstitial thermotherapy guided by real-time thermal MRI as an alternative to separation surgery in the management of spinal metastasis. (2015) (71)
- Reversible, strokelike migraine attacks in patients with previous radiation therapy. (2003) (71)
- Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. (2016) (71)
- Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks (2010) (71)
- A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma (2007) (71)
- Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. (2020) (71)
- Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. (2009) (71)
- Stereotactic radiosurgery for brainstem metastases: Survival, tumor control, and patient outcomes. (2007) (71)
- North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme. (2011) (70)
- Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. (2004) (69)
- Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. (2017) (69)
- Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG. (2014) (68)
- Management of low-grade glioma: a systematic review and meta-analysis. (2018) (68)
- Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525 (2017) (67)
- Choroid Plexus Papillomas: A Single Institutional Experience (2004) (67)
- Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. (2014) (67)
- The neurocognitive effects of radiation in adult low-grade glioma patients. (2003) (67)
- A Prospective Study of Quality of Life in Adults With Newly Diagnosed High-Grade Gliomas: Comparison of Patient and Caregiver Ratings of Quality of Life (2008) (66)
- Repeat radiosurgery for idiopathic trigeminal neuralgia. (2005) (65)
- Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. (2011) (65)
- Therapeutic Exercise during Outpatient Radiation Therapy for Advanced Cancer: Feasibility and Impact on Physical Well-Being (2010) (64)
- Factors Associated With Endocrine Deficits After Stereotactic Radiosurgery of Pituitary Adenomas (2010) (64)
- Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. (2009) (63)
- Quality of Life of Caregivers of Patients With Advanced-Stage Cancer (2006) (62)
- Progress Toward Long-Term Survivors of Glioblastoma. (2019) (62)
- Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. (2014) (61)
- Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases from 1985 to Today. (2020) (60)
- Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 (2016) (58)
- Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. (2010) (57)
- Measuring spiritual quality of life in patients with cancer. (2007) (56)
- Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. (2013) (56)
- Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus. (2019) (55)
- Depression in glioma: a primer for clinicians and researchers (2013) (55)
- The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases. (2017) (53)
- Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. (2008) (53)
- Role of a Medical Social Worker in Improving Quality of Life for Patients with Advanced Cancer with a Structured Multidisciplinary Intervention (2007) (53)
- A Multi-Institutional Analysis of Presentation and Outcomes for Leptomeningeal Disease Recurrence After Surgical Resection and Radiosurgery for Brain Metastases. (2019) (53)
- Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. (2017) (52)
- Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. (2013) (51)
- An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts. (2000) (51)
- Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis. (2013) (50)
- Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. (2010) (50)
- Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. (2017) (50)
- Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. (2014) (50)
- Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. (2017) (50)
- Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. (2008) (46)
- Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. (2020) (46)
- Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. (2016) (46)
- Selective Serotonin Reuptake Inhibitors, Glioblastoma Multiforme, and Impact on Toxicities and Overall Survival: The Mayo Clinic Experience (2011) (46)
- Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial (2020) (46)
- Metastatic Spinal Cord Compression In Patients With Colorectal Cancer (1999) (46)
- Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults (2018) (46)
- Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice (2013) (46)
- Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. (2013) (45)
- Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG) (2008) (45)
- Treatment of brain metastases from melanoma. (2003) (45)
- Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: A randomized controlled trial (2007) (45)
- Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade (2017) (44)
- Low‐grade gliomas in older patients (2009) (44)
- Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospective Trials. (2015) (43)
- Spinal Laser Interstitial Thermal Therapy: A Novel Alternative to Surgery for Metastatic Epidural Spinal Cord Compression. (2016) (43)
- Is there a role for radiation therapy in the management of Hürthle cell carcinoma? (2003) (43)
- Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. (2014) (43)
- Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials (2016) (43)
- Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525. (2018) (42)
- Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. (2016) (42)
- The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma (2018) (42)
- Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool (2018) (41)
- Adult Low-grade Glioma: 19-year Experience at a Single Institution (2013) (40)
- Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. (2014) (40)
- Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials (2009) (39)
- Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. (2006) (39)
- Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline. (2022) (39)
- Astroblastomas: a Surveillance, Epidemiology, and End Results (SEER)-based patterns of care analysis. (2014) (38)
- Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules (2015) (38)
- Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. (2018) (37)
- Epidemiology of synchronous brain metastases (2020) (37)
- Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience. (2008) (36)
- Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomas. (2002) (36)
- The Evolving Role of Tumor Treating Fields in Managing Glioblastoma (2017) (36)
- Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review. (2019) (36)
- N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease (2016) (35)
- Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG). (2006) (35)
- The use of spine stereotactic radiosurgery for oligometastatic disease. (2016) (34)
- Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry (2013) (34)
- Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. (2015) (34)
- Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review. (2014) (34)
- NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM). (2019) (33)
- Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer (2018) (33)
- Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches. (2019) (33)
- Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. (2012) (33)
- Caregivers of Patients With Cancer Fatigue (2014) (33)
- Gamma knife radiosurgery of radiation-induced intracranial tumors: local control, outcomes, and complications. (2005) (33)
- Preoperative Stereotactic Radiosurgery for Brain Metastases (2018) (33)
- Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience. (2014) (33)
- Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial (2012) (33)
- Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. (2018) (33)
- Clinical and prognostic features of adult patients with gangliogliomas. (2013) (32)
- Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials (2016) (32)
- CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design. (2020) (31)
- Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival. (2020) (31)
- Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. (2015) (30)
- BMET-05NCCTG N0574 (ALLIANCE): A PHASE III RANDOMIZED TRIAL OF WHOLE BRAIN RADIATION THERAPY (WBRT) IN ADDITION TO RADIOSURGERY (SRS) IN PATIENTS WITH 1 TO 3 BRAIN METASTASES (2015) (30)
- Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM). (2013) (30)
- A methodology to determine margins by EPID measurements of patient setup variation and motion as applied to immobilization devices. (2004) (30)
- Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression. (2017) (29)
- A pilot study of high‐dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0–N3M0 squamous cell carcinoma of the upper aerodigestive tract (2005) (29)
- The Diminishing Role of Whole-Brain Radiation Therapy in the Treatment of Brain Metastases (2017) (29)
- Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials. (2016) (28)
- Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database (2018) (28)
- Radiosurgery as Primary Management for Meningiomas Extending into the Internal Auditory Canal (2004) (27)
- Postoperative Stereotactic Radiosurgery Versus Observation for Completely Resected Brain Metastases: Results of a Prospective Randomized Study (2016) (27)
- The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study. (2019) (26)
- Stereotactic radiosurgery for recurrent or unresectable pilocytic astrocytoma. (2011) (26)
- A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma. (2021) (26)
- Melanoma-induced brain metastases (2008) (26)
- The results of radiotherapy for brainstem tumors (1998) (26)
- Generalizable class solutions for treatment planning of spinal stereotactic body radiation therapy. (2011) (26)
- Brain Metastases From Melanoma: Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy? (2010) (25)
- Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA) (2019) (25)
- Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases (2018) (25)
- Resolution of diabetes insipidus following gamma knife surgery for a solitary metastasis to the pituitary stalk. Case report. (2004) (25)
- Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases (2019) (24)
- Neurocognitive Function Following Therapy for Low-Grade Gliomas. (2015) (23)
- Successful treatment of severe extremity pain in myelofibrosis with low‐dose single‐fraction radiation therapy (2010) (23)
- NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001 (2018) (23)
- Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance). (2015) (23)
- Neurocognition in individuals with incidentally-identified meningioma (2017) (23)
- CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III Randomized Study of RT vs. RT+TMZ vs. TMZ for Newly Diagnosed 1p/19q-Codeleted Anaplastic Oligodendroglial Tumors. Analysis of Patients Treated on the Original Protocol Design (PL02.005) (2016) (23)
- A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy (2016) (22)
- Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity. (2008) (22)
- Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases. (2018) (22)
- Multidisciplinary patient-centered management of brain metastases and future directions (2020) (21)
- Gamma knife stereotactic radiosurgery in the treatment of brainstem metastases: The MD Anderson experience. (2015) (21)
- Management and Survival of Adult Patients with Pilocytic Astrocytoma in the National Cancer Database. (2018) (21)
- Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. (2017) (20)
- Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes. (2017) (20)
- Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques. (2018) (20)
- The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic. (2015) (20)
- Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases. (2020) (20)
- Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma. (2020) (19)
- Long‐term follow‐up of stereotactic radiosurgery for head and neck malignancies (2015) (18)
- Whole brain radiotherapy for brain metastases (2016) (18)
- The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma (2017) (17)
- Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability. (2018) (17)
- Exploring primary brain tumor patient and caregiver needs and preferences in brief educational and support opportunities (2015) (17)
- Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. (2018) (17)
- Treatment and long-term outcomes in pituitary carcinoma: a cohort study. (2019) (17)
- Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma (2016) (16)
- ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN. (2015) (16)
- Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. (2015) (16)
- The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases. (2011) (16)
- The role of image-guided intensity modulated proton therapy in glioma. (2017) (16)
- Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis (2013) (16)
- Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3). (2019) (15)
- Protons vs Photons for Brain and Skull Base Tumors. (2018) (15)
- Neurocognitive aspects of brain metastasis. (2018) (15)
- Treatment options for brain metastases from melanoma (2005) (15)
- Melanoma brain metastases harboring BRAFV600K or NRAS mutations are associated with an increased local failure rate following conventional therapy (2018) (14)
- Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. (2017) (14)
- Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a north central cancer treatment group (NCCTG) prospective study (2003) (14)
- Therapeutic management of gliosarcoma in the temozolomide era. (2015) (14)
- Percutaneous surgery for treatment of epidural spinal cord compression and spinal instability: technical note. (2016) (14)
- Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience (2017) (13)
- Feasibility of Radiosurgical Decompression of Metastatic Epidural Spinal Cord Compression (MESCC) in Nonoperable Patients (2012) (13)
- Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. (2004) (13)
- Risk of vertebral compression fracture specific to osteolytic renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study. (2015) (13)
- Organ preservation for advanced laryngeal carcinoma (2006) (13)
- Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme (2012) (13)
- Prophylactic cranial irradiation: recent outcomes and innovations. (2014) (13)
- CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. (2011) (13)
- Informed consent in advanced laryngeal cancer (2007) (13)
- Initial Results of a Phase II Trial of 18f-Dopa Pet-guided Dose-escalated Radiotherapy for Glioblastoma (2020) (12)
- The Future Is Now—Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018! (2018) (12)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (12)
- CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES (2017) (12)
- Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas. (2021) (12)
- Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases (2019) (11)
- Updates in the management of intradural spinal cord tumors: a radiation oncology focus. (2019) (11)
- The use of image guided laser interstitial thermotherapy to supplement spine stereotactic radiosurgery to manage metastatic epidural spinal cord compression: Proof of concept and dosimetric analysis. (2016) (11)
- Dose Escalated Radiotherapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials. (2021) (11)
- Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress? (2019) (11)
- AT-13R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE (2014) (11)
- A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM) (2008) (11)
- Fatigue randomized controlled trials-how tired is "too tired" in patients undergoing glioma treatment? (2016) (11)
- Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. (2019) (10)
- Low-grade gliomas: The debate continues (2006) (10)
- Stereotactic radiosurgery for intraventricular brain metastases. (2014) (10)
- Radiosurgery for Small-Cell Brain Metastases: Challenging the Last Bastion of Preferential Whole-Brain Radiotherapy Delivery. (2020) (10)
- Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report (2008) (10)
- Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation. (2018) (10)
- Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM) (2005) (9)
- Same, better, or worse? Neurocognitive effects of radiotherapy for low-grade gliomas remain unknown (2009) (9)
- Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy (2018) (9)
- The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy. (2018) (9)
- Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. (2019) (9)
- Innovation in the management of brain metastases. (2007) (9)
- The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study. (2014) (9)
- Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA). (2015) (9)
- Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma. (2003) (8)
- Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era. (2018) (8)
- Cognitive sequelae of brain radiation (2012) (8)
- Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung (2015) (8)
- A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis (2020) (7)
- Nodular Leptomeningeal Disease – A Distinct Pattern of Recurrence after Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability (2018) (7)
- Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma. (2019) (7)
- RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival. (2005) (7)
- Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM (2010) (7)
- Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis (2021) (7)
- Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). In reply to Drs. Larson and Sahgal. (2009) (7)
- Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. (2013) (7)
- Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. (2021) (7)
- Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology. (2018) (7)
- Low-Grade Glioma (2018) (7)
- Empowering Residents into Independent Practice: A Single-Institutional Endeavor Aimed at Developing Resident Autonomy Through Implementation of a Chief Resident Service in Radiation Oncology. (2020) (6)
- Submillimeter alignment of more than three contiguous vertebrae in spinal SRS/SBRT with 6‐degree couch (2017) (6)
- Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes (2019) (6)
- Biological Effective Dose as a Predictor of Hypopituitarism after Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Cohort Study of Patients Treated Using Contemporary Techniques (2020) (6)
- NCCTG 94–72-53: Diagnostic and prognostic significance of 1p and 19q deletions in patients (pts) with low-grade oligodendroglioma and astrocytoma (2005) (6)
- Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. (2012) (6)
- Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy (2021) (6)
- Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825). (2021) (6)
- ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG). (2015) (6)
- Adult CNS Radiation Oncology (2018) (6)
- Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases. (2022) (6)
- Local control after brain-directed radiation in patients with cystic versus solid brain metastases (2019) (6)
- The role of whole‐brain radiation therapy in patients with cerebral metastases (2018) (6)
- Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations (2022) (6)
- Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3) (2020) (6)
- Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (2019) (5)
- The Effect of Gene Mutations on Survival in Patients With Adenocarcinoma of the Lung Following the Development of Brain Metastases (2015) (5)
- A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. (2016) (5)
- Factors Associated With Meningioma Detected in a Population‐Based Sample (2019) (5)
- Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials (2015) (5)
- Irrational fear of whole‐brain radiotherapy: Are we doing our patients a disservice? (2018) (5)
- Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study (2020) (5)
- The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience (2021) (5)
- Multimodality management of brain metastasis from colorectal cancer. (2020) (5)
- ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS (2017) (5)
- Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG) (2014) (5)
- Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. (2018) (5)
- Willingness of cancer patients to help family members to quit smoking (2011) (5)
- Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery†. (2015) (5)
- Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline (2022) (4)
- Oncodiagnosis panel: 2002. Patient's symptoms not related to the lesion seen in the MR images. (2003) (4)
- Development and internal validation of an RPA-based model predictive of pain flare incidence after spine SBRT. (2022) (4)
- NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients. (2009) (4)
- Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study. (2020) (4)
- NEURO/MEDICAL ONCOLOGY (2013) (4)
- Brain metastases: fractionated whole-brain radiotherapy. (2018) (4)
- Radiosurgery followed by tumour treating fields (TTFields) for brain metastases (1-10) from NSCLC in the phase III METIS trial (2019) (4)
- Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial. (2021) (4)
- BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA) (2016) (4)
- TU-D-207B-01: A Prediction Model for Distinguishing Radiation Necrosis From Tumor Progression After Gamma Knife Radiosurgery Based On Radiomics Features From MR Images. (2016) (4)
- Temporally-Dependent Intracranial Control of Melanoma Brain Metastasis by Stereotactic Radiation Therapy in Patients Treated With Immune Checkpoint Blockade (2015) (4)
- Dosimetric impact of esophagus motion in single fraction spine stereotactic body radiotherapy (2019) (4)
- Significant Preservation of Neurocognitive Function (NCF) and Patient-Reported Symptoms with Hippocampal Avoidance (HA) during Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Final Results of Nrg Oncology CC001 (2019) (4)
- Brain metastases resection cavity radio—surgery based on T2-weighted MRI: technique assessment (2020) (4)
- Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. (2022) (4)
- Irradiation of the inguinal lymph nodes in patients of differing body habitus: a comparison of techniques and resulting normal tissue complication probabilities. (2004) (4)
- Assembling the brain trust: the multidisciplinary imperative in neuro-oncology (2019) (4)
- Hippocampal Avoidance Prophylactic Cranial Irradiation: A New Standard of Care? (2021) (4)
- Oncodiagnosis Panel: 2002 - Adult Central Nervous System Neoplasms (2003) (3)
- Outcomes After Surgery and Radiation Therapy for Spinal Myxopapillary Ependymoma (2012) (3)
- Timing, presentation, and patterns of failure of leptomeningeal disease after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis. (2018) (3)
- CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE) (2020) (3)
- Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma (2022) (3)
- The effects of radiation on cognative function in patients with low-grade glioma (2001) (3)
- In regard to Yamamoto et al. (2012) (3)
- Modern reirradiation for recurrent gliomas can safely delay tumor progression. (2018) (3)
- Intensity modulated radiation therapy class solutions in Philips Pinnacle treatment planning for central nervous system malignancies: Standardized, efficient, and effective. (2012) (3)
- Alliance A071701: Genomically guided treatment trial in brain metastases. (2020) (3)
- An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma (2022) (3)
- Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience (2020) (3)
- Treatment of Brain Metastases with Stereotactic Radiosurgery and Immune Checkpoint Inhibitors: An International Meta-Analysis of Individual Patient Data (2018) (3)
- Validation of single item Linear Analogue Scale Assessments (LASAs) for assessing quality of life (QOL) in patients with newly diagnosed high-grade gliomas. (2006) (3)
- Prospective evaluation of target and spinal cord motion and dosimetric changes with respiration in spinal stereotactic body radiation therapy utilizing 4-D CT. (2016) (3)
- Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era (2013) (3)
- SU-E-T-410: Spine Radiosurgery Imaging Guidance Using ExacTrac and CT on rails. (2012) (3)
- Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins. (2016) (3)
- Oncodiagnosis panel: 2002. Metastatic NSCLC. (2003) (3)
- ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001 (2019) (3)
- ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA) (2015) (3)
- The Impact of Insulin-like Growth Factor Index and Biological Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly (2019) (3)
- Radiotherapy and Systemic Lupus Erythematosus: The Mayo Clinic Experience (2007) (3)
- Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors. (2018) (3)
- Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis. (2019) (3)
- Prospective validation of treatment accuracy using implanted fiducial markers for spinal stereotactic body radiation therapy. (2016) (2)
- Proton and Carbon Ion Therapy for Skull Base Chordomas. (2020) (2)
- Cancer treatment impact on cognitive functioning and quality of life in lung cancer survivors. (2010) (2)
- Linear Accelerator–Based Stereotactic Ablative Radiation Therapy Reirradiation for Unresectable Recurrent Head and Neck Cancer (2016) (2)
- Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient‐level data from 4 prospective trials (2022) (2)
- Complications of Therapy (2011) (2)
- ACTR-12. PRELIMINARY SAFETY AND EFFICACY OF A PHASE II TRIAL OF 18F-DOPA PET-GUIDED, DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA (2018) (2)
- CLIN-RADIATION THERAPY (2012) (2)
- Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials (2020) (2)
- METIS: A phase 3 study of radiosurgery with TTFields for 1-10 brain metastases from NSCLC. (2017) (2)
- NCCTG N047D: Relationship between phase II endpoints of 12 month overall survival and 6 month progression-free survival for glioblastoma multiforme (GBM) phase II trials (2005) (2)
- Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3) (2019) (2)
- NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial. (2012) (2)
- Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery (2021) (2)
- Treatment Responses and Survival in IDH1-Mutant Grade II and III Gliomas in NRG Oncology/RTOG 9802 and 9813 (2016) (2)
- Prognostic Factors in Patients with Renal Cell Carcinoma and Brain Metastases (2017) (2)
- Deep Learning-Based Automatic Detection of Brain Metastases in Heterogenous Multi-Institutional MRI Sets: An Exploratory Analysis of NRG CC001. (2022) (2)
- Dosimetric Comparison of Gamma Knife Extend to Linear Accelerator Base Volumetric Modulated Arc Therapy Plans for Fractionated Stereotactic Radiosurgery (2015) (2)
- The Role of Biological Effective Dose in Predicting Obliteration After Stereotactic Radiosurgery of Cerebral Arteriovenous Malformations. (2021) (2)
- Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. (2022) (2)
- The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience. (2021) (2)
- Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic (2022) (2)
- RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM) (2019) (2)
- Pediatric, Intracranial, Low-Grade Glioma; 20-year Experience With Long-Term Follow-up at the Mayo Clinic (2007) (2)
- Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression (2021) (2)
- SRS versus WBRT for resected brain metastases - Authors' reply. (2017) (2)
- Gamma Knife Stereotactic Radiosurgery for Trigeminal Neuralgia Secondary to Recurrent Skull Base Malignancies (2016) (2)
- Long-term Results of a Phase I/II Study of High-Dose Thoracic Radiotherapy With Concomitant Cisplatin and Etoposide in Limited Stage Small-Cell Lung Cancer (2001) (2)
- Risk of Late Toxicity After Radiotherapy in Patients With Connective Tissue Disorders: Association With Connective Tissue Disorder Severity (2007) (1)
- NCCTG Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination with Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme Patients 1 (2011) (1)
- BMET-32OUTCOMES OF GAMMA KNIFE RADIOSURGERY IN BRAIN METASTASES FROM NEUROENDOCRINE TUMORS (2015) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival (2006) (1)
- Development and validation of a recursive partitioning analysis–based pretreatment decision‐making tool identifying ideal candidates for spine stereotactic body radiation therapy (2022) (1)
- ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2017) (1)
- Long Term Outcome of Resected Choroid Plexus Papillomas. Is There a Role for Radiation?: 11:07 Am (16) (2002) (1)
- NCO-14PRE-TREATMENT HIPPOCAMPAL VOLUME PREDICTS NEUROCOGNITIVE FUNCTION (NCF) FOR PATIENTS TREATED WITH HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY (HA-WBRT) FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0933 (2015) (1)
- Abstract CT161: METIS: A phase 3 study of radiosurgery with TTFields for 1-10 brain metastases from NSCLC (2017) (1)
- Abstract A110: EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial. (2013) (1)
- A Multi-institutional Analysis of Patterns of Salvage Therapy for Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases (2019) (1)
- Effect of combined therapy with temsirolimus (CCI-779), temozolomide (TMZ), and radiation (RT) in newly diagnosed glioblastoma multiforme (GBM) patients on immune suppression: Results from NCCTG N027D. (2010) (1)
- SYMPTOM MANAGEMENT/QUALITY OF LIFE (2013) (1)
- Cost utility analysis of a randomized radiation therapy trial among patients with one to three brain metastases. (2014) (1)
- Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time? (2017) (1)
- 30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL (2020) (1)
- Single Versus Multifraction Spine Stereotactic Radiosurgery for Spine Metastases From Renal Cell Carcinoma: Secondary Analysis of Phase I/II Trials (2015) (1)
- EP-1239: Ph II randomized trial comparing cognitive outcomes of proton vs. photon radiation for glioblastoma (2018) (1)
- Missing repeated measures data in clinical trials. (2021) (1)
- Leptomeningeal disease following local brain irradiation: A new frontier. (2019) (1)
- Efficacy of Radiotherapy for Primary NHL of the Parotid: 11:06 AM (22) (2002) (1)
- Development and Internal Validation of an RPA-Based Model Predictive of Pain Flare Incidence After Spine SBRT. (2021) (1)
- Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (2019) (1)
- Linear Analog Scale Assessment (2014) (1)
- Epidemiologic study of risk factors for meningioma in the Mayo Clinic Study of Aging. (2017) (1)
- Factors Influencing Vertebral Compression Fracture Specific to Renal Cell Carcinoma Spinal Metastases After Stereotactic Body Radiation Therapy: A Multi-institutional Study (2014) (1)
- Concurrent Temozolomide and Radiation in Elderly Patients with Glioblastoma: A Retrospective Analysis (2011) (1)
- Comparing Cognitive Decline after Radiotherapy for Brain Metastases: A Meta-Analysis of Prospective Trials (2019) (1)
- Hippocampal Avoidance Prophylactic Cranial Irradiation: Interpreting the Evidence. (2021) (1)
- Does adjuvant radiotherapy for primary adenoid cystic carcinoma of the parotid gland reduce the risk for loco-regional recurrence and associated morbidity? (2000) (1)
- RBTT-02. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL (2019) (1)
- Pituitary carcinoma: The University of Texas MD Anderson Cancer Center experience. (2017) (1)
- Chapter 26 – Low-Grade Gliomas (2016) (1)
- RTHP-35. LOCAL RECURRENCE PATTERN OF PATIENTS ENROLLED ON A RANDOMIZED STUDY OF POST-OPERATIVE STEREOTACTIC RADIOSURGERY VS OBSERVATION FOR COMPLETELY RESECTED BRAIN METASTASIS (2017) (1)
- RTHP-11. THE EFFECT OF PRESCRIPTION ISODOSE LINE ON LOCAL CONTROL AND RADIOGRAPHIC RESPONSE IN GAMMA KNIFE RADIOSURGERY OF VESTIBULAR SCHWANNOMA (2019) (1)
- Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline (2021) (1)
- Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment (2021) (1)
- Oncodiagnosis panel: 2002. Primary glial neoplasm or less likely an intracranial abscess. (2003) (1)
- Phase I/II Trial of Single Fraction Stereotactic Body Radiotherapy for Previously Un-irradiated Spinal or Paraspinal Metastases (2011) (1)
- Hypofractionated Dose-Escalation for Elderly Patients With a Newly Diagnosed Glioblastoma Improves Survival. (2021) (1)
- RTHP-02. IMPACT OF 18F-DOPA PET ON RADIOTHERAPY TARGET VOLUMES FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS; PRELIMINARY RESULTS OF A PHASE II DOSE-ESCALATION TRIAL (2018) (1)
- Spine Stereotactic Radiosurgery for Metastatic Pheochromocytoma (2019) (1)
- Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma. (2020) (1)
- Cognitive outcomes in patients with low-grade glioma. (2021) (1)
- Patterns of Failure and Outcomes Based On Management of Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases: A Multi-Institutional Analysis (2018) (1)
- Stereotactic Spinal Radiosurgery and Delayed Vertebral Fracture Risk (2018) (1)
- Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO) (2019) (1)
- Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. (2020) (1)
- NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM) (2019) (1)
- RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA (2018) (1)
- Stereotactic Radiosurgery for Head and Neck Malignancies (2013) (1)
- Abstract CT151: TTFields and radiosurgery for 1 to 10 brain metastases from NSCLC in the phase III METIS study (2018) (1)
- Medical and Neuro-Oncology (2010) (1)
- Hippocampal Avoidance Prophylactic Cranial Irradiation for SCLC. (2021) (1)
- Association of aggressive resection with survival and progression-free survival in adult low-grade glioma: A systematic review and meta-analysis with numbers needed to treat. (2017) (1)
- Spinal Cord Astrocytomas: Treatment Considerations (2007) (1)
- The Cognitive Effects of Radiotherapy for Brain Metastases (2022) (1)
- Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy (2022) (0)
- A Prospective Study of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors in Adults. (2022) (0)
- In reply to Prabhu et Al. (2012) (0)
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS (2020) (0)
- RTHP-23. PROSPECTIVE TRIAL OF CONVENTIONALLY FRACTIONATED DOSE CONSTRAINTS FOR RE-IRRADIATION OF PRIMARY BRAIN TUMORS (2019) (0)
- SU-E-T-541: A Clinical Approach to Account for the Attenuation of Varian Exact IGRT Couch Top for Spine Stereotatic Radiosurgery Patients (2011) (0)
- Chemotherapy and Dose-adapted Radiotherapy (RT) for Central Nervous System (CNS) Germinoma: Long Term Follow-up of the Mayo Clinic Experience (2008) (0)
- BI-12RTOG 0525 RECURSIVE PARTITIONING ANALYSIS BASED ON CLINICAL AND PROTEIN BIOMARKER PARAMETERS (2014) (0)
- Reply to S.G. Chun et al, A. Levy et al, and N. Andratschke et al. (2020) (0)
- Exposure to Radon and Heavy Particulate Pollution and Incidence of Brain Tumors. (2022) (0)
- Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-Year Single Institution Experience (2014) (0)
- Comparison of First-Line Radiosurgery for Small-Cell and Non-Small Cell Lung Cancer Brain Metastases (Cross-FIRE). (2023) (0)
- ASSESSING NEUROCOGNITIVE STATUS IN NEWLY PRESENTING PATIENTS WITH SUPRATENTORIAL INTRACRANIAL TUMOURS (2012) (0)
- RTHP-30. DOES THE TEMPORAL LOBECTOMY CAVITY NEED TO BE IRRADIATED? PATTERNS OF RECURRENCE AND IMPLICATIONS FOR POSTOPERATIVE RADIATION TREATMENT FIELD DESIGN FOR TEMPORAL LOBE GLIOMAS. (2019) (0)
- Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules (2015) (0)
- Evaluation of Scanning Beam Proton Therapy for Medulloblastoma Boost Treatment (2012) (0)
- Spinal Cord Tolerance After High Dose, De Novo, Single Fraction Spine Stereotactic Radiosurgery (2020) (0)
- Toxicity Profile of Spine Stereotactic Radiosurgery Among Long-Term Survivors (2016) (0)
- Advanced radiation therapeutics for the central nervous system (2017) (0)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (0)
- NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT (2019) (0)
- Early Pulmonary Toxicity of Lung Stereotactic Body Radiation Therapy (SBRT) Delivered as Consecutive Daily Fractions (2010) (0)
- BMET-16GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES USING ONLY 3 PINS. (2015) (0)
- N997D: Pilot trial of CPT11 during RT followed by CPT11 and BCNU in newly diagnosed glioblastoma (GBM) patients: A North Central Cancer Group (NCCTG) study (2005) (0)
- An Evaluation of Multi-Institutional Data-Transfer to Facilitate Personalized Computational Modeling (2014) (0)
- Whole-Brain Radiotherapy for Brain Metastases: Is the Therapeutic Window Enlarging? (2015) (0)
- Fractionated Radiotherapy for Spine Tumors (2011) (0)
- NCI pilot intervention program to assist accrual for challenging late-phase clinical trials. (2014) (0)
- ATCT-29INVESTIGATING THE EFFECT OF REIRRADIATION OR SYSTEMIC THERAPY IN PATIENTS WITH GBM AFTER TUMOR PROGRESSION: A SECONDARY ANALYSIS OF THE NRG ONCOLOGY/RTOG 0525 (2015) (0)
- P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study (2018) (0)
- The utility of PET/CT imaging of head and neck cancer performed early after surgical resection and prior to adjuvant radiation therapy (2006) (0)
- Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy (2022) (0)
- Quantifying the benefit of chemotherapy and radiation in low-grade glioma: A systematic review and meta-analysis of numbers needed to treat. (2017) (0)
- EP-1097: A prospective study of thyroid function after radiotherapy for central nervous system and head and neck malignancies (2014) (0)
- RTHP-18. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR NEWLY DIAGNOSED GBM: SECONDARY ANALYSIS COMPARISON OF GENDER AND NEUTROPHIL-LYMPHOCYTE RATIO (NLR) IN GBM OUTCOMES (2019) (0)
- Factors Associated with Pituitary Insufficiency after Stereotactic Radiosurgery of Patients with Nonfunctioning Pituitary Adenomas (2008) (0)
- Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from NSCLC in the phase 3 METIS study (2019) (0)
- Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma (2022) (0)
- 18F-DOPA-PET-Guided Re-Irradiation for Recurrent High-Grade Glioma: Initial Results of a Phase II Trial. (2021) (0)
- ACTR-07. LONG-TERM OUTCOMES FROM INTERGROUP NCCTG 86-72-51 (ALLIANCE): FINAL REPORT OF A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF HIGH DOSE VERSUS LOW DOSE RADIATION IN ADULT SUPRATENTORIAL LOW-GRADE GLIOMA (2019) (0)
- Evaluation of Intrafraction Motion in 1000 Fractions of Spine Stereotactic Radiation Therapy (2015) (0)
- P2.01-63 Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial (2019) (0)
- Longitudinal assessment of cognitive impairment among lung cancer survivors. (2009) (0)
- Lessons learned from proton vs photon radiation therapy for glioblastoma signal-finding trial. (2022) (0)
- Adjuvant Radiotherapy following Gross total Resection of WHO Grade II Meningioma (2017) (0)
- Memantine for Mitigation of Neurocognitive Toxicity Following Radiation to the Brain (2021) (0)
- Brain Metastases Resection Cavity Radiosurgery Based Primarily on T2-weighted MRI: Technique Assessment (2020) (0)
- Clinical Outcomes and Toxicity using Stereotactic Body Radiotherapy (SBRT) for Stage IV Melanoma (2011) (0)
- P2.01-70 Tumor Treating Fields and Radiosurgery for Supra- and/or Infratentorial Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Study (2018) (0)
- Patient-reported Quality of Life during Photon and Proton Radiation Therapy: Results of a Prospective Registry of Patient Reported Outcomes in a Large-Volume, Multi-Site Practice (2018) (0)
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS (2020) (0)
- Adjuvant Hypofractionated Intensity Modulated Radiation Therapy (IMRT) After Resection of Regional Lymph Node (LN) Metastases in Patients With Malignant Melanoma of the Head and Neck (2012) (0)
- Pituitary carcinoma: The University of Texas MD Anderson Cancer Center experience (2018) (0)
- Modern Re-irradiation Versus Post-Bevacizumab Salvage Chemotherapy in Treating Recurrent High-Grade Gliomas (2018) (0)
- Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas. (2023) (0)
- Association of Circulating Markers with Cognitive Decline After Radiation Therapy for Brain Metastasis. (2022) (0)
- MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS (2016) (0)
- Cancer esearch cer Therapy : Clinical bination of Temsirolimus ( CCI-779 ) with Chemoradiation ewly Diagnosed Glioblastoma Multiforme ( GBM ) CTG trial N 027 D ) Is Associated with R eased Infectious Risks (2010) (0)
- Abstract 532: Circulating myeloid precursor profile as potential marker to differentiate radiation changes from tumor recurrence after brain stereotactic radiosurgery (2015) (0)
- Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933 (2021) (0)
- Central neurocytomas, the Mayo Clinic experience (2004) (0)
- Chapter 24 – Low-Grade Gliomas (2012) (0)
- Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825 (2015) (0)
- SU‐FF‐T‐93: A Clinical Comparison of Two IMRT Planning Systems for Small Field Conformal Therapy of Intracranial Lesions (2005) (0)
- Reply to v.R. Bhatt et Al and m.C. Chamberlain. (2013) (0)
- Treatment-Plan Comparison of Three Advanced Radiation Treatment Modalities for Fractionated Stereotactic Radiotherapy to the Head and Neck (2019) (0)
- Postoperative Cavity Image-Guided Stereotactic Radiotherapy Outcomes (2016) (0)
- We thank Chamberlain and Silbergeld 1 for their thoughtful letter regarding our article entitled, "Summary Report on the Graded Prog- nostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases." 2 (2012) (0)
- P19.06 Radiosurgery followed by Tumor Treating Fields for brain metastases (1-10) from NSCLC in the phase 3 METIS trial (2021) (0)
- Chemotherapy Plus Proton or Photon Radiation on a Trial. (2018) (0)
- Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques. (2022) (0)
- Erratum: Organ preservation for advanced laryngeal carcinoma (Head and Neck (2006) 28 (689-696) DOI: 10.1002/hed.20387) (2007) (0)
- TU-C-12A-02: Development of a Multiparametric Statistical Response Map for Quantitative Imaging. (2014) (0)
- Abstract C56: NCCTG phase I trial of everolimus (RAD001) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients (2009) (0)
- Use of three pins in Gamma Knife stereotactic radiosurgery for brain metastases. (2019) (0)
- The Effect of Gene Mutations on Survival in Patients With Melanoma Following the Development of Brain Metastases (2016) (0)
- Association Of Radon And High Particulate Pollution With Incidence Of Brain Tumors In The United States (2020) (0)
- NCO-01NEUROPSYCHOLOGICAL PROFILES IN INDIVIDUALS WITH INCIDENTAL MENINGIOMA (2015) (0)
- Post-Resection Stereotactic Radiosurgery in the Treatment of Brain Metastases (2018) (0)
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS (2017) (0)
- QLIF-04. MEASURING MOBILITY AND DISABILITY IN PATIENTS WITH GLIOMAS (2016) (0)
- Short reply to "Proton therapy for newly diagnosed glioblastoma: More room for investigation" by R. Press et al. (2021) (0)
- Seed, soil, and spine stereotactic radiosurgery: A unique case of metastatic dissemination. (2020) (0)
- Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial (2022) (0)
- Reply to M.C. Chamberlain et al (2012) (0)
- Abstract CT172: Phase III METIS study: Tumor Treating Fields (150 kHz) and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from non-small cell lung cancer (NSCLC) (2019) (0)
- Pilocytic Astrocytoma Survival in Adults: Analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (S45.004) (2012) (0)
- In reply to Dr. Khandelwal (2007) (0)
- 2412 : Primary and Post-Operative Radiation Therapy Based on CT Simulation, Functional Outcome, and Larynx Preservation in Squamous Cell Carcinoma of the Tongue Base (2006) (0)
- Incidence and Predictive Factors of Pain Flare After Spine Stereotactic Radiosurgery (2014) (0)
- Five Decades of Adult Low-grade Gliomas: Patterns of Care Over Time (2012) (0)
- Radiosurgery and immune checkpoint inhibition in the treatment of brain metastases: A meta-analysis of patient-level data. (2018) (0)
- An Externally Validated RPA-Based Pre-Treatment Decision-Making Tool Identifying Ideal Candidates for Spine SBRT (2022) (0)
- 391 Stereotactic Radiosurgery for Intermediate and High-Grade Arteriovenous Malformations: Outcomes Stratified by the Supplemented Spetzler-Martin Grading System (2022) (0)
- In Response to Pohar (2008) (0)
- Outcomes and Toxicities of Stereotactic Body Radiation Therapy (SBRT) for Nonspine Osseous Oligometastases (2013) (0)
- SU‐FF‐J‐58: Evaluation of Immobilization Devices Using EPID Measurements of Patient Set Up Variations (2006) (0)
- PITUITARY TUMOR TYPE AFFECTS THE CHANCE OF BIOCHEMICAL REMISSION AFTER RADIOSURGERY OF HORMONE‐SECRETING PITUITARY ADENOMAS (2008) (0)
- 159TiPTTFields and radiosurgery for 1-10 brain metastases from NSCLC: The Phase 3 METIS study (2017) (0)
- Trimodality Therapy is Associated with Improved Overall Survival in Gliosarcoma: A Multi-Site Experience (2020) (0)
- Response to Letter to Editor. (2020) (0)
- EP-1354: Impact of evaluation timing in determining patterns of failure in glioblastoma (2015) (0)
- Maximum PTV Dose Predicts for Radiation Pneumonitis Following Lung Stereotactic Body Radiation Therapy (2011) (0)
- Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG). (2004) (0)
- SU‐E‐T‐244: Should Treatment Time Be Included in Assessing the Quality of a Gamma Plan? (2011) (0)
- PO-0762: Low-grade gliomas in older adults: treatment patterns and outcomes over the past fifty years (2015) (0)
- Assessing simple measures of patient-reported (PR) fatigue for oncology clinical trials: A pooled analysis of 3,915 patients. (2009) (0)
- Local Control and Radiographic Response as a Function of Isodose Adjustment in Stereotactic Radiosurgery Treatment for Sporadic Vestibular Schwannoma (2020) (0)
- Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas. (2020) (0)
- NC-05ASSOCIATION OF NEUROCOGNITIVE AND PATIENT REPORTED OUTCOMES WITH THE PRESENCE OF RESIDUAL DISEASE FOLLOWING SURGICAL RESECTION IN GLIOBLASTOMA (GBM) (2014) (0)
- Long-Term Outcomes of Grade I–II Skull Base Chondrosarcoma: An Insight into the Role of Surgery and Radiotherapy (2021) (0)
- QL-07TREATMENT OF FATIGUE IN A PATIENT WITH CORPUS-CALLOSUM GLIOMA AND ATYPICAL SLEEP DISORDER (2014) (0)
- NCOG-04. ANALYSIS OF EXAMINER ERRORS ON COGNITIVE TESTING IN MULTI-SITE STUDIES (2017) (0)
- Single-Isocenter Multitarget Stereotactic Radiosurgery is Associated with Less Long-Term Radionecrosis Compared with Gamma Knife for Multiple Brain Metastasis (2019) (0)
- Operations Management in Radiation Oncology: Standardizing Radiation Treatment Scheduling Timelines Using a Data-Driven Tier System (2019) (0)
- Patterns of Failure in Stereotactic Body Radiation Therapy for Spinal Tumors (2013) (0)
- A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue in patients with high-grade glioma (Alliance A221101). (2020) (0)
- MS-12TEMOZOLOMIDE-BASED THERAPY FOR THE MANAGEMENT OF PROGRESSIVE PITUITARY CARCINOMA (2014) (0)
- Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. (2022) (0)
- Reply to Drs. Mulvenna and Holt (2011) (0)
- High dose intra-arterial cisplatin with concomitant accelerated radiotherapy for patients with T4 and selected T3, N0-3, M0 head and neck cancer. (2004) (0)
- METIS: A phase III study of radiosurgery with TTFields for 1-10 brain metastases from NSCLC (2016) (0)
- Phase II trial of irinotecan (CPT-11) and radiation followed by irinotecan and BCNU in glioblastoma patients (pts). (2006) (0)
- Factors Affecting Endocrine Cure after Radiosurgery in Patients with Acromegaly: 896 (2006) (0)
- Deferring a Change in the Standard of Care for Small Cell Lung Cancer Brain Metastases-Reply. (2020) (0)
- Single-fraction Stereotactic Radiosurgery for Atypical Meningiomas (WHO grade II): Treatment Results Based on a 25-year Experience (2021) (0)
- P2.06-034 METIS: A Phase 3 Study of Radiosurgery with TTFields for 1-10 Brain Metastases from NSCLC: Topic: Radiotherapy, TT Fields (2017) (0)
- TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL (2019) (0)
- Effects o f R adiotherapy o n C ognitive F unction i n P atients With L ow-Grade G lioma M easured b y t he F olstein Mini-Mental S tate E xamination (2003) (0)
- Leptomeningeal disease after surgical resection and radiosurgery for brain metastases and neurologic death: A multi-institutional analysis. (2020) (0)
- Tobacco use among radiation oncology outpatients. (2004) (0)
- Diagnostic and prognostic significance of a t(1;19)(q10;p10) in patients (pts) with low-grade oligodendroglioma and astrocytoma: NCCTG 94-72-53. (2016) (0)
- NCOG-04. PRETREATMENT VOLUME OF MR-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS NEUROCOGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT+MEMANTINE FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGYCC001 (2020) (0)
- RTRB-03SHORT DELAY IN INITIATION OF RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR GLIOBLASTOMA: A SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0525 AND 0825 (2015) (0)
- The Effect of Prescription Isodose Variation on Tumor Control and Toxicities in Stereotactic Radiosurgery for Sporadic Vestibular Schwannoma: Propensity Score-Matched Case–Control Study (2021) (0)
- Accelerated Hypofractionation for Elderly or Frail Patients with a Newly Diagnosed Glioblastoma Improves Survival (2021) (0)
- CLIN-MEDICAL + RADIATION THERAPIES (2012) (0)
- Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images (2018) (0)
- CLIN-NEURO-COGNITIVE (2012) (0)
- Stereotactic Body Radiotherapy for the Management of Spinal Metastasis from Renal Cell Carcinoma (2020) (0)
- Dose painting with Gamma Knife: Two techniques for delivering different doses to areas of recurrent or residual tumor after resection of brain metastases. (2015) (0)
- In response to Bolukbasi et al. (2020) (0)
- Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas (2022) (0)
- MS-20LEPTOMENINGEAL DISSEMINATION IN RELAPSED ADULT MEDULLOBLASTOMA: PATTERNS OF DISEASE AND ROLE OF INTRATHECAL CHEMOTHERAPY (2014) (0)
- Comparative Analysis of Coplanar vs. Noncoplanar Planning Approaches in Extra-cranial Stereotactic Radiotherapy (SBRT) of Early Stage Peripheral Non-Small Cell Lung Cancer (NSCLC) (2009) (0)
- 5520 POSTER Primary and post-operative radiation therapy for squamous cell carcinoma of the tonsil: a retrospective review of a single institution's experience during the CT simulation era (2007) (0)
- Spine Stereotactic Radiosurgery in the Treatment of Metastatic Pheochromocytoma: An Updated Case Series (2018) (0)
- BMET-03. METIS: A PHASE III STUDY OF RADIOSURGERY WITH TTFIELDS FOR 1-10 BRAIN METASTASES FROM NSCLC (2016) (0)
- Low-grade gliomas in older adults : treatment patterns and outcomes over the past fifty years (2010) (0)
- Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases (2018) (0)
- De Novo Versus Progression of an Existing Vertebral Compression Fracture (VCF) Following Spine Stereotactic Body Radiation Therapy (SBRT): Separate Risk Profiles to Consider (2014) (0)
- Adjuvant Radiation Therapy for Pleural Mesothelioma after Extrapleural Pneumonectomy (EPP) or Pleurectomy and Decortication (P+D) (2020) (0)
- CLIN-NEURO/MEDICAL ONCOLOGY (2012) (0)
- Local Control After Resection And Adjuvant Radiosurgery Compared To Radiosurgery Alone For Brain Metastasis: Exploratory Analysis Of Alliance NCCTG N107C (2020) (0)
- Initial Provider and Patient-Reported Outcomes of a Phase II Study of Short Course Hypofractionated Proton Beam Therapy Incorporating 18F-DOPA-PET/MRI for Elderly Patients with Newly Diagnosed Glioblastoma (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paul David Brown?
Paul David Brown is affiliated with the following schools:
